SBP variability predicts poor outcomes in elderly
Variability in systolic BP is a major risk factor for adverse cardiovascular events in the elderly and should be targeted to reduce risk, Melbourne research suggests.
For hypertensive patients over the age of 65, high rates of visit-to-visit SBP variation doubled the risk of fatal and non-fatal first cardiovascular events compared to those with stable SBP, a new analysis of data from the Australian National Blood Pressure study (ANBP-2) has shown.
The risk of adverse outcomes with SBP variability was seen across all age groups and in patients who met BP targets. SBP variability was